Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    ECX.DE Net Margin

    As of 2025-07-06, the Net Margin of Epigenomics AG (ECX.DE) is -2479.2%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    ECX.DE Net Margin - Historical Value
    DateValue
    2022-12-31 -2479.2%
    2021-12-31 -39.1%
    2020-12-31 -1387.9%
    -
    -
    -
    -
    -
    -
    -
    ECX.DE Net Margin - Peers Comparison
    TickerNameValue
    ACOU.STAcousort AB-318.3%
    ADXN.SWAddex Therapeutics Ltd1720.8%
    AFMDAffimed NV-1280.2%
    ALONX.PAOnxeo SA-1355.6%
    ALPHA.PAPharnext SA-6865339%
    ASIT.BRDMS Imaging SA-23200%
    B8F.DEBiofrontera AG-1.1%
    BIO.DEBiotest AG3.6%
    BIO.MCBiosearch SA5.9%
    BIO.WABioton SA-7.5%
    BIOPOR.COBioporto A/S-188.3%
    BNTXBiontech SE-24.2%
    BONEH.HEBBS-Bioactive Bone Substitutes Oyj-
    BOTHE.BRBone Therapeutics SA-1292.5%
    CIR.LCircassia Group PLC12.9%
    CNTGCentogene NV-73.2%
    COX.PANicox SA-848.6%
    CVACCureVac NV30.3%
    CYXO.STCyxone AB-19817.2%
    DEST.LDestiny Pharma PLC-54100%
    DNL.LDiurnal Group PLC-353.8%
    ERYP.PAErytech Pharma SA-3.4%
    FYB.DEFormycon AG-180.4%
    HPHA.DEHeidelberg Pharma AG-283%
    IMTXImmatics NV9.8%
    ISOFOL.STIsofol Medical AB (publ)-5141.6%
    KAN.STKancera AB-45000%
    MOR.DEMorphoSys AG-79.6%
    OASM.STOasmia Pharmaceutical AB-506.7%
    OKYO.LOKYO Pharma Ltd-
    OPTI.LOptiBiotix Health PLC-316.6%
    PA8.DEPaion AG-1.7%
    POLN.SWPolyphor AG-314.8%
    TNG.PATransgene SA-292.5%
    VICO.STVicore Pharma Holding AB-154.2%
    VVY.ASVivoryon Therapeutics NV-117.6%
    Tickers added to watchlist